Literature DB >> 27402174

Evaluation of calibration-free concentration analysis provided by Biacore™ systems.

Ewa Pol1, Håkan Roos2, Francis Markey2, Fredrik Elwinger2, Alan Shaw3, Robert Karlsson2.   

Abstract

Surface Plasmon Resonance biosensors measure the interaction between a molecule in solution and its interaction partner attached to a sensor surface. Under certain conditions, the observed binding rate can be used directly to obtain the concentration of the molecule in solution, without the use of any standard. This type of assay is referred to as Calibration Free Concentration Analysis, CFCA. By examining experimental conditions, including immobilization levels and temperature, for a range of analytes, and by using global analysis of several sample dilutions, conditions that gave the most robust results were identified. These conditions provided the concentration values that were on average ∼15% lower than those obtained using other methods. The accuracy of the concentration determined may be related to how the analyte is distributed in the dextran matrix and to its distance from the gold surface, and may thereby depend on the conversion of the SPR signal to mass. A good precision of CFCA, ∼8% (n = 21), was demonstrated when this method was used to efficiently guide purification procedures of Interferon α-2a. In this paper, the theory behind CFCA and the future developments, as well as the application of CFCA for absolute and relative concentration measurements (including the assessment of the potency of a biotherapeutic medicine) are discussed, and new evaluation tools that broaden the range of applications, are introduced.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Biacore; Biosimilar; CFCA; SPR

Mesh:

Substances:

Year:  2016        PMID: 27402174     DOI: 10.1016/j.ab.2016.07.009

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  9 in total

1.  VHH characterization. Comparison of recombinant with chemically synthesized anti-HER2 VHH.

Authors:  Lucie Hartmann; Thomas Botzanowski; Mathieu Galibert; Magali Jullian; Eric Chabrol; Gabrielle Zeder-Lutz; Valérie Kugler; Johann Stojko; Jean-Marc Strub; Gilles Ferry; Lukasz Frankiewicz; Karine Puget; Renaud Wagner; Sarah Cianférani; Jean A Boutin
Journal:  Protein Sci       Date:  2019-08-29       Impact factor: 6.725

Review 2.  Biosensor binding data and its applicability to the determination of active concentration.

Authors:  Robert Karlsson
Journal:  Biophys Rev       Date:  2016-10-17

3.  Anti-CD40 antibody 2C10 binds to a conformational epitope at the CD40-CD154 interface that is conserved among primate species.

Authors:  Anthony J Michaels; Matteo Stoppato; Walter J Flores; Keith A Reimann; Kathleen D Engelman
Journal:  Am J Transplant       Date:  2019-09-12       Impact factor: 8.086

4.  Active Opto-Magnetic Biosensing with Silicon Microring Resonators.

Authors:  Piero Borga; Francesca Milesi; Nicola Peserico; Chiara Groppi; Francesco Damin; Laura Sola; Paola Piedimonte; Antonio Fincato; Marco Sampietro; Marcella Chiari; Andrea Melloni; Riccardo Bertacco
Journal:  Sensors (Basel)       Date:  2022-04-25       Impact factor: 3.847

5.  Surrogate potency assays: Comparison of binding profiles complements dose response curves for unambiguous assessment of relative potencies.

Authors:  Robert Karlsson; Veronica Fridh; Åsa Frostell
Journal:  J Pharm Anal       Date:  2017-12-21

6.  Unlocking latent kinetic information from label-free binding.

Authors:  John G Quinn; Micah Steffek; John M Bruning; Alexandra Frommlet; Melinda M Mulvihill
Journal:  Sci Rep       Date:  2019-12-05       Impact factor: 4.379

7.  A rebinding-assay for measuring extreme kinetics using label-free biosensors.

Authors:  John G Quinn
Journal:  Sci Rep       Date:  2021-04-15       Impact factor: 4.379

8.  Multi-temperature experiments to ease analysis of heterogeneous binder solutions by surface plasmon resonance biosensing.

Authors:  Olivier Henry; Gregory De Crescenzo; Jimmy Gaudreault; Yves Durocher
Journal:  Sci Rep       Date:  2022-08-24       Impact factor: 4.996

9.  Measuring the Impact of Targeting FcRn-Mediated IgG Recycling on Donor-Specific Alloantibodies in a Sensitized NHP Model.

Authors:  Miriam Manook; Walter J Flores; Robin Schmitz; Zachary Fitch; Janghoon Yoon; Yeeun Bae; Brian Shaw; Allan Kirk; Melissa Harnois; Sallie Permar; Alton B Farris; Diogo M Magnani; Jean Kwun; Stuart Knechtle
Journal:  Front Immunol       Date:  2021-06-02       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.